Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-18 4:07 pm Purchase | 2025-11-10 | 13G | Keros Therapeutics, Inc. KROS | ExodusPoint Capital Management, LP | 1,907,899 6.300% | 1,907,899 (New Position) | Filing History |
| 2025-08-18 7:27 pm Purchase | 2025-08-11 | 13G | ALT5 Sigma Corporation ALTS | ExodusPoint Capital Management, LP | 5,856,700 4.750% | 5,856,700 (New Position) | Filing History |
| 2024-02-07 4:05 pm Sale | 2023-12-31 | 13G | Elevation Oncology, Inc. ELEV | ExodusPoint Capital Management, LP | 50,000 0.100% | -1,364,824 (-96.47%) | Filing History |
| 2023-06-09 4:15 pm Purchase | 2023-06-05 | 13G | Elevation Oncology, Inc. ELEV | ExodusPoint Capital Management, LP | 1,414,824 5.800% | 1,414,824 (New Position) | Filing History |